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ABSTRACT 
The spread of antibiotic-resistant pathogens requires new treatments. Small molecule 
precursor compounds that produce oxidative biocides with well-established antimicrobial 
properties could provide a range of new therapeutic products to combat resistant infections. 
The aim of this study was to investigate a novel biomaterials-based approach for the 
manufacture, targeted delivery and controlled release of a peroxygen donor (sodium 
percarbonate) combined with an acetyl donor (tetraacetylethylenediamine) to deliver local 
antimicrobial activity via a dynamic equilibrium mixture of hydrogen peroxide and peracetic 
acid. Entrapment of the pre-cursor compounds into hierarchically structured degradable 
microparticles was achieved using an innovative dry manufacturing process involving 
thermally induced phase separation (TIPS) that circumvented compound decomposition 
associated with conventional microparticle manufacture. The microparticles provided 
controlled release of hydrogen peroxide and peracetic acid that led to rapid and sustained 
killing of multiple drug-resistant organisms (methicillin-resistant Staphylococcus aureus and 
carbapenem-resistant Escherichia coli) without associated cytotoxicity in vitro nor 
intracutaneous reactivity in vivo. The results from this study demonstrate for the first time 
that microparticles loaded with acetyl and peroxygen donors retain their antimicrobial activity 
whilst eliciting no host toxicity. In doing so, it overcomes the detrimental effects that have 
prevented oxidative biocides from being used as alternatives to conventional antibiotics. 
 
KEYWORDS: Thermally induced phase separation; oxidative biocide; antimicrobial 
agent, resistance, antibiotics
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1. INTRODUCTION 
Many antibiotics, antiseptics and disinfectants developed to date are susceptible to bacterial 
resistance[1-3]. There is, therefore, an urgent need to find alternative antimicrobial compounds that 
provide broad spectrum activity to which resistance is less likely to be present. Re-evaluation of 
existing high energy oxidative species, such as hydrogen peroxide (H2O2) and peracetic acid (PAA), 
with well-established biocidal properties could provide a range of new therapeutic products[2].  
PAA does not give rise to bacterial resistance, whereas some resistance can occur to H2O2 for 
organisms producing catalase and dismutase enzymes[4, 5]. However, when used alone, these 
low-molecular weight oxidising agents offer limited clinical therapeutic potential since they pass 
easily through cell membranes and at high local concentrations lead to cell death, causing 
unwanted off-target tissue damage[6, 7]. To date, safe and efficacious delivery of oxidative species 
into sites of infection without causing unacceptable tissue damage has proven to be challenging[8-
10].  
Controlled delivery of potentially toxic compounds for use in other areas of biomedicine (e.g. 
cancer chemotherapy) has seen development of a range of innovative particulate-based delivery 
systems that provide localized, sustained release of compounds at sub-toxic levels[11-13]. 
However, loading precursors of oxidative species, such as tetraacetylethylenediamine (TAED) and 
sodium percarbonate (SP), into delivery systems is particularly challenging because exposure to 
aqueous environments typically associated with conventional microparticle manufacture processes 
results in rapid decomposition into secondary products (Figure 1).  
Chemical degradation of precursor compounds during manufacture may also be affected by pH, 
ionic strength, light and environmental temperature[14, 15]. To achieve effective localized and 
sustained release, physicochemical properties of the delivery system must be compatible with the 
bioavailability/bioactivity of the entrapped pre-cursor compound and capable of releasing the 
oxidative species in a controlled manner without causing toxicity to surrounding tissue[13, 16, 17]. 
SP and TAED are non-toxic solid compounds, if used at low concentrations, with exceptional 
storage stability. SP forms sodium carbonate (SC) and H2O2 when it comes into contact with 
aqueous media[18]. H2O2 react with TAED through hydrolysis and perhydrolysis to produce 
triacetylethylenediamine (TriAED) and diacetylethylenediamine (DAED), resulting in the release of 
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two moles of PAA or acetic acid (AA) (see Figure 1)[19]. As a biocidal system this mixture is more 
effective than H2O2 alone in terms of contact time, antimicrobial activity spectrum and activity in 
environmental conditions where there is a heavy organic load that might attenuate the activity of 
the oxidative biocide [20, 21]. 
Synthetic polymer-based devices are widely used in clinic for sustained drug delivery (e.g. Ozurdex, 
Zoladex, Risperdal Consta). The active ingredient is entrapped in a polymer matrix, such as 
poly(lactic-co-glycolic acid)  (PLGA)[12, 22]. When implanted into the body the active ingredient is 
gradually released as the polymer degrades[16, 23]. This approach could lend itself to the 
sustained release of TAED and SP if the compounds can be entrapped without exposure to an 
aqueous environment during the manufacturing process. Thermally induced phase separation 
(TIPS) microparticle manufacturing uses lyophilisation to remove residual solvent instead of 
aqueous-based washing used with conventional solvent-evaporation microparticle manufacturing 
techniques. 
The aim of this was study was to investigate whether entrapping oxidative species precursor 
compounds into biodegradable polymer microparticles using TIPS technology[24] provides a 
method for reducing local toxicty of the compounds whilst retaining their antimicrobial activity.  
2. EXPERIMENTAL SECTION 
2.1 Preparation of solutions  
Poly(lactic-co-glycolic) acid (PLGA) PURASORB 7507 (75:25) polymer (Corbion, Amsterdam, 
Netherlands) was dissolved in dimethyl carbonate - DMC (Sigma Aldrich, Dorset, UK) overnight to 
produce a 4% (w/v) polymeric solution. TAED (Warwick Chemicals, Holywell, UK) was mixed with 
acetonitrile - ACN (Sigma Aldrich) at a concentration of 200mg/ml and stirred for 1 hour using a 
magnetic stirrer. The TAED+ACN suspension was added to the PLGA solution (11% v/v) and 
stirred for a further 30 minutes before use. SP (Solvay, Warrington,UK) was mixed with analytical 
grade water – AGW (200mg/ml) and stirred for 1 hour using a magnetic stirrer. The SP+AGW 
suspension was added to the PLGA+DMC solution (11% v/v) and stirred for a further 30min. 
2.2 Preparation of TIPS microparticles  
TIPS microparticles were prepared using a VAR-D modular microencapsulation unit (NISCO 
Engineering AG, Zurich, Switzerland; Frequency: 2.75 KHz, Amplitude: 70%) fitted with a sapphire 
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tipped nozzle (150µm orifice). The flow rate of polymer solution delivered into the unit was 3ml/min. 
The polymer droplets were collected in liquid nitrogen (LN2) and the solvent removed by 
lyophilisation for 48 hours. The dried microparticles were sieved to a size range of 250-425µm 
before being stored under vacuum in sealed glass containers at 4°C.  
2.3 Characterization of TIPS microparticles  
2.3.1 Scanning Electron Microscopy (SEM): Microparticles were vacuum-coated with 
gold/palladium for 120s and images using JEOL USA JSM-7610F SEM. Size distribution: 
Morphologi G3 (Malvern Company, Worcestershire, UK) was used to characterise the size and 
shape of the microparticles using static image analysis.  
2.3.2 Differential scanning calorimetry (DSC): Measurements were performed on a TA Instruments 
Q2000 DSC (TA Instruments, Waters, LLC, USA) equipped with a refrigerating cooling accessory 
and using nitrogen as a purge gas at a flow rate of 50mL/min. Cell constant and enthalpy 
calibration was performed with standard indium according to the manufacturer’s instructions. 
Samples were heated in Tzero® aluminium pans and lids at 10 °C/min to 100 or 200 °C. Data were 
collected using TA Advantage software and analysed using TA Universal Analysis 2000 (TA 
Instruments, Waters, LLC, USA). Transition temperatures were reported as extrapolated onset 
and/or peak point calculated along with the enthalpy using the sigmoidal peak integration function. 
Glass Transition (Tg) were reported as the midpoint at the inflection.  
2.3.3 Thermogravimetric analysis (TGA): TA Instruments Discovery TGA (TA Instruments, Waters, 
LLC, USA) was used to measure weight change upon heating at 10 °C/min up to 350 °C using 
nitrogen as a purge gas at a flow rate of 25 mL/min. The machine was calibrated for weight and 
temperature according to the manufacturer’s instructions. Data collection and analysis were 
performed using TA Instruments Trios software (TA Instruments, Waters, LLC, USA).  
2.3.4 Powder X-ray diffraction (PXRD): measurements were performed on Rigaku Mini 600 
(Rigaku, Tokyo, Japan), operated with Cu Kα radiation (1.5418 Å) at 40 kV and 15 mA), between 5 
and 35 ° at 2 °/min speed and 0.02° step size. 
2.4 Loading efficiency for TAED and SP in TIPS microparticles  
2.4.1 TAED: The method published by Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 
Germany was followed to detect the entrapment efficiency of TAED in the TIPS microparticles[25]. 
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A standard calibration of 0–100 ppm was prepared in acetonitrile. Approximately 10 mg of the TIPS 
microparticles were dissolved in 100 ml of acetonitrile. The standards and samples were run on a 
gas chromatography–mass spectrometer (GC-MS) with an HP5-MS UI 30m x 0.250mm x 0.25um 
[19091S-433UI] column.  
2.4.2 SP: The entrapment efficiency of SP in the microparticles was measured using a 
spectrophotometric method developed in-house. A calibration curve was prepared using SP (Acros 
Organics and previously titrated as 74.0% w/w active SP) dissolved in ultra-pure water. Specific 
volumes of the SP solution containing known quantities of SP were added to ammonium 
molybdate solution, acetate buffer and potassium iodide solution, which were then incubated in the 
dark for 10 minutes and the optical density measured at 352 nm after subtracting the blank 
background. A known quantity of the microparticles loaded with SP were washed with acetonitrile. 
The sample was centrifuged, the acetonitrile removed and a fresh volume added. The sample was 
washed a total of three times. The remaining SP residue was added to ammonium molybdate 
solution, acetate buffer and potassium iodide solution, which were then incubated in the dark for 10 
minutes and the optical density measured at 352 nm after subtracting the background from the 
blank. 
2.5 Microbiology studies 
2.5.1 All microbiology studies were conducted by the Environmental Research Laboratory, 
University College Hospital. Target organisms: Clinical isolates of carbapenem-resistant E.coli 
(CREC) and methicillin-resistant Staphylococcus aureus (MRSA; EMRSA-15 variant B1). 
Preparation of bacteria: 10 µL of test bacteria was transferred with a loop to sterile nutrient broth 
(10mL; Oxoid, UK), mixed thoroughly and incubated aerobically at 37°C for ~24h (±4h). Broth 
cultures were centrifuged at 3000rpm (1500 x g; Jouan CR3i centrifuge: Thermo, UK) for 10 
minutes and the remaining pellet re-suspended in 10mL of sterile distilled water (DW). During time-
kill assays, the PAA antimicrobial agent was inactivated after the appropriate contact time by the 
addition of a neutralising solution [3% (w/v) Tween 80, 0.3% (w/v) Lecithin, 1.0 % (w/v) Sodium 
thiosulfate, 1.5% (w/v) K2HPO4, KH2PO4 0.05% (w/v), 1% (w/v) Poly-[sodium-4-styrenesulfonate], 
0.1% (v/v) Triton® X100 (Sigma-Aldrich, UK) and prepared in phosphate-buffered saline (PBS) 
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solution (Oxoid, UK)]. Neutralising solutions were sterilised by autoclaving (121°C for 15minutes) 
and refrigerated (2-8°C) until required.  
2.5.2 Validation of neutraliser efficacy and toxicity: The ability of the neutraliser to quench the 
antimicrobial activity of microparticles loaded with TAED was confirmed and any toxicity against 
the test organisms assessed as previously described[26]. An aliquot (80mg) of the test (TAED+SP) 
and control (unloaded) microparticle preparation was inoculated with 8mL sterile DW, mixed at 
high speed for 30 seconds and hydrated at room temperature for 1.5hours to allow the 
antimicrobial to leach into the solution. One millilitre aliquots from the resulting microparticle-
leachate (free-of microparticles) was transferred to a separate container. A sterile test tube was 
dosed with: (A) 1mL neutraliser + 1mL microparticle leachate, (B) 1mL neutraliser A + 1mL sterile 
distilled water, 1mL microparticle leachate (no-antimicrobial) or (D) 2mL distilled water (control) 
and incubated at room temperature for 1minute to allow neutralisation of the microparticle-leachate 
solution. This was inoculated with 1mL (103 colony-forming units [cfu]) of CREC or MRSA prepared 
in sterile distilled water. The resulting suspensions were incubated a further 10 minutes at room 
temperature before spread-plating 0.1mL onto Columbia blood agar plates (a simple non-selective 
medium). Plates were incubated aerobically (CREC, MRSA) at 37oC for 48hrs.  
2.5.3 Determination of bactericidal/bacteriostatic nature of TIPS microparticles loaded with SP and 
TAED: Preparations of control (80mg: unloaded) and test (40mg TAED + 40mg SP - loaded) 
microparticles were activated by adding 8mL Eagle’s Minimum Essential Medium (EMEM) (Sigma 
Aldrich, UK), 10% v/v fetal bovine serum (FBS) (Sigma Aldrich), 2 mM L-Glutamine (Sigma Aldrich) 
(complete EMEM), mixing by vortex for 30 seconds and incubating for 1.5 hours at room 
temperature. One mL aliquots of the hydrated microparticle suspension were transferred to 
individual universal tubes. Each microparticle aliquot was inoculated with 1.0mL of the test 
suspension (~106cfu bacteria) prepared in sterile phosphate-buffered saline [PBS]) and the 
suspension mixed by vortex shaking for 30 seconds. Inoculated suspensions were incubated 
aerobically and without agitation at 37°C for a further 6 hours after which the antimicrobial activity 
was stopped by adding 0.1mL of neutralising solution followed by incubation at room temperature 
for a further 10 minutes. After neutralisation, suspensions were centrifuged at 3000rpm (~1100x g) 
for 10 minutes. The resulting supernatant was discarded and the pellet resuspended in 2mL sterile 
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PBS and washed by vortexing at high speed for 30 seconds and repeating the centrifugation and 
wash stages for a total of three washes. The final (washed) pellet was resuspended in 2mL sterile 
PBS as previous. One-hundred millilitre aliquots of serial dilutions (1/1, 1/10, 1/100 and 1/1000) of 
the washed suspensions were spread-plated onto Columbia Blood agar and incubated aerobically 
at 37°C for 48 h prior to counting the bacterial cfu formed in the agar plates. Tests were repeated 
six times. 
2.5.4 Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the 
antimicrobial compounds: The release of oxidative biocides from the TAED precursor loaded 
microparticles is dependent on the presence of H2O2 released from the SP-loaded microparticles. 
Therefore TAED microparticles alone did not have any bactericidal action. Based on the intended 
combined use of TAED and SP loaded microparticles, the MIC and MBC were performed only for 
PLGA-TAED-SP microparticles. Preparations of loaded and unloaded microparticles were hydrated 
with EMEM as described above. Serial dilutions of each suspension (unloaded and TAED+SP 
microparticles) were prepared in 10% increments ranging from 0% to 100% of the original 
suspension using sterile nutrient broth (Oxoid, UK). Aliquots (1mL) of each concentration was 
transferred to a sterile 24 well microplate (Corning® CellBIND®, Sigma-Aldrich, UK). Overnight 
cultures of CREC and MRSA were prepared in nutrient broth as previously described after which 
serial 1/10 dilutions of the initial suspension performed to achieve a stock inoculum concentration 
of approximately 106 cfu/mL. One millilitre aliquots of the test bacterial inoculum was transferred to 
each microplate-well pre-dosed with the test antimicrobial suspension and mixed gently by 
forward/backward pipetting. The microplates were incubated aerobically for ~24 hours at 37°C 
after which 0.1mL of the neutraliser solution was added to each well and incubated at room 
temperature for 10 minutes. The quantity of bacteria present was determined by plating 0.1mL and 
0.5mL from each well onto a blood agar plate and incubated a further 24 hours at 37°C prior to 
counting the bacteria CFU formed in the agar plates. 
2.5.5 Antimicrobial activity of loaded TIPS microparticles: The bactericidal activity of loaded and 
unloaded microparticles was evaluated using a time-kill suspension-assay based upon BS EN 
1276 protocols for antimicrobial efficacy testing of bactericidal agents against CREC and MRSA. 
Briefly, the microparticles (control: 80mg unloaded and test: 40mg TAED + 40mg SP - loaded) 
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were activated by adding 8mL complete EMEM, mixed by vortex for 30 seconds and incubated for 
1.5 hours at 37°C. Immediately after hydration, 1 mL of the test bacterial suspension (~106cfu 
CREC or MRSA, prepared in sterile complete EMEM medium was added to 1mL of complete 
EMEM medium (this functioned as the interfering substance/soil simulating an organic challenge). 
The resulting suspension was transferred to 8mL of the hydrated microparticle suspension and 
mixed by vortexing for 30 seconds.  Solutions were incubated at 37°C for contact times of: 0, 1, 2, 
4, 6 and 18 hours after which bactericidal activity was stopped by transferring 1mL of the 
suspension to 1mL neutralising solution followed by incubation at room temperature for 10 
minutes.  Serial dilutions (1/1, 1/10 and 1/100) of suspensions were performed prior to spread-
plating 0.1mL and 0.5mL aliquots onto Columbia blood agar (CBA) plates.  Plates were incubated 
aerobically at 37oC for 48 h prior to counting the bacteria CFU formed in the agar plates. Tests 
were repeated nine times.  
To investigate the ability of the loaded microparticles to exhibit longer term antimicrobial activity 
against CREC and MRSA the incubation period of the microparticles (control: 80mg unloaded and 
test: 40mg TAED + 40mg SP - loaded) were activated by adding 8mL complete EMEM, mixed by 
vortex for 30 seconds and incubated for 14 days at 37°C with agitation by vortex for 30 seconds 
daily. At pre-determined intervals (i.e. 1, 2, 3, 7 and 14 days) 0.5mL aliquots of the microparticle 
suspension was transferred to individual 30 ml containers. Each aliquot was inoculated with 0.5mL 
of a bacterial inoculum preparation - (~106cfu CREC or MRSA, prepared in sterile EMEM) and the 
suspension mixed by vortex. The microparticle-inoculum mix was incubated at 37°C for contact 
times of: 0, 1, 2, 4, 6 and 18 hours after which bactericidal activity was stopped by the addition of 
0.5mL neutralising solution followed by incubation at room temperature for 10 minutes. Serial 
dilutions (1/1, 1/10 and 1/100) of the neutralised suspensions were spread-plated onto Columbia 
blood agar plates. Plates were incubated aerobically at 37oC for 48 h prior to counting the bacteria 
CFU formed in the agar plates.  Tests were repeated six times.  
2.6 In vitro cytotoxicity  
Cytotoxicity of microparticles loaded with TAED and SP and the compounds in their raw format 
were evaluated in vitro using the CellTox™ Green cytotoxicity assay (Promega UK) and L929 
fibroblasts. The cells were mixed with the CellTox dye according to the kit manufacturer’s 
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instructions, transferred into a black walled 96 well plate (5,000 cells per well) and incubated for 24 
hours a 37°C, 5% CO2. 50µl of the supernatant was collected from microparticles that had been 
hydrated sterile complete EMEM medium (10mg/ml) for pre-determined amounts of time (1.5h, 1d, 
3d, 7d and 14 days) and added to the cells in the 96 well plate. Fluorescence readings were 
collected from the wells after different periods of incubation (30min, 90min, 3h, 5h and 24h; 
TECAN GENios Multifunction Fluorescence Microplate Reader; excitation wavelength of 485–
500nm and emission of 520–530nm). Readings from test samples were normalised with lysed 
samples representing 100% toxicity. 
2.7 In vivo biocompatibility  
18 Sprague Dawley male rats (weight 385±15g) were used to investigate the intracutaneous 
reactivity of the microparticles. Following anaesthetisation with inhaled isoflurane and 
administration of an analgesic (Carprofen - 0.1mL/kg) the fur on the dorsum was trimmed with 
clippers and then shaved with a disposable razor. The skin was cleaned with chlorhexidine in 
alcohol before surgery and allowed to dry. Immediately before delivery, the microparticles were 
mixed into a clear viscous inert hydrogel (50 mg/ml; GranuGEL® ConvaTec, UK) to facilitate 
delivery through a 16G needle. The rats (n=6) were randomly assigned to 3 groups to receive a 
subcutaneous injection of microparticles loaded with either TAED (100µl), SP (100µl) or a 
combination of TAED and SP microparticles (100µl each; total volume 200µl). Each animal 
received a second subcutaneous injections in the dorsum containing an equivalent volume of 
unloaded TIPS microparticles. The injection site was identified with a permanent marker and 
photographed. At 7, 14 and 21 days post-delivery, 2 rats from each group were terminated using 
an intraperitoneal injection of sodium pentobarbitone. The microparticle injection area was trimmed 
and shaved and the area photographed. The implant site and surrounding 5 mm of tissue was 
excised and placed into 4% neutral buffered formaldehyde for 24 hours fixation. The in vivo study 
was conducted by Northwick Park Institute for Medical Research (PPL 80/2639). The experimental 
protocol was approved by the Institutional Animal Care and Use Committee of NPMIR. 
2.8 Histology  
The fixed tissue samples were washed in PBS and dehydrated in a graded series of alcohol before 
being embedded in Paraplast X-tra® (Sigma). Tissue sections (5 µm) were cut from the wax blocks 
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before staining with haematoxylin and eosin. Images were acquired using a Hamamatsu 
Nanozoomer-HT-2.0 Digital pathology System (NDP).  
2.9 Statistical analysis 
Data were tested for Gaussian distribution and analysed statistically using OriginPro and 
GraphPad Prism software. For data sets with a Gaussian distribution statistical evaluation was 
performed by Two-Way ANOVA with Dunnett's test for multiple comparisons. For data sets with a 
non-Gaussian distribution statistical evaluation was performed by the Friedman test. 
3. RESULTS 
3.1 Characterization of TIPS microparticles 
TIPS microparticles investigated in the study had a mean diameter of 383 ± 41 µm. Scanning 
electron microscopy revealed unloaded microparticles prepared from 4 wt% PLGA had highly 
ordered interconnected pores, with a single larger on the surface of each microparticle (Figures 
2a-c).  At higher magnification the morphology of the PLGA TIPS particles had a highly anisotropic 
channel-like structure with an internal ladder-like shape, similar to that previously described[24]. 
The exterior of the unloaded microparticles contained pores between 1–5 µm arranged in a 
chevron like pattern. Microparticles loaded with TAED exhibited noticeably different surface 
morphology and pore size. Microparticles loaded with SP appeared to be more porous compared 
with the unloaded microparticles, possibly due to the small amount of water introduced to the 
polymer mix to dissolve the SP.  
Particle morphology transformed after hydration for 28 days in Eagle’s minimum essential medium 
(EMEM media) due to PLGA degradation and the release of the TAED and SP compounds from 
the PLGA matrix due to diffusion and hydrolysis (Figures 2d-f). 
PLGA thermograms obtained by differential scanning calorimetry (DSC) showed glass transition 
temperatures (Tg)  of 48.8oC and 50.2oC for unloaded TIPS microparticles and pure PLGA polymer, 
respectively, which is in accordance with reported values in the literature[22, 31]. The characteristic 
enthalpy of relaxation endotherm overlapped with the Tg (Figure 3a). The slight difference in the Tg 
could relate to moisture content reflected in a mass loss in the thermogravimetric analysis (TGA) of 
2.3% and 1% for unloaded microparticles and pure PLGA polymer, respectively in the temperature 
range up to 200oC (Figure 3b). The Tg value of the microparticles loaded with SP was slightly 
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lower than unloaded microparticles despite having a mass loss of 7% up to 200oC. SP appeared to 
be stable within the temperature range for studying the PLGA Tg (up to 120oC) but showed a rapid 
mass loss indicating degradation with TGA (onset 152oC, 29% up to 200oC), with the loss 
increasing to 36% when incorporated into the PLGA microparticles. The DSC thermogram of SP 
clearly showed an exotherm indicating the thermal degradation of this compound, and the shoulder 
showing at the beginning of the exothermic peak indicated its multi-step nature that is 
characteristic of SP[27]. This exotherm was also observed in the DSC thermogram of PLGA TIPS 
particles containing SP, which was followed by an endotherm. The presence of PLGA appears to 
affect the kinetics of the thermal degradation of SP resulting in a decrease of the onset 
temperature of this chemical reaction as well as showing the endothermic part of the reaction. The 
DSC signal was the sum of the overlapping endothermic and exothermic processes at a specific 
temperature range. Therefore, any change to these processes will have resulted in a change to 
this overall signal.      
TAED showed two endotherms with peak values of 145oC and 150oC but only one endotherm with 
a peak value of around 134oC, indicating melting (Figure 3a). The Tg microparticles loaded with 
TAED (47oC) was slightly lower than the unloaded microparticles. This could indicate an interaction 
between TAED and PLGA polymer resulting in a lower Tg for PLGA and melting temperature (Tm) 
for TAED. The TGA data depicted in Figure 3b indicate that TAED showed a mass loss of 45% 
appearing as a single transition with an onset of 187oC. This changed to a two-step mass loss in 
the microparticles loaded with TAED, with onset occurring at 155oC and 322oC corresponding to a 
mass loss of 27% and 30%, respectively. 
Powder X-ray diffraction (PXRD) patterns (see Figure 3d) revealed unloaded microparticles to be 
amorphous, similar to the starting raw polymer, whereas SP and TAED in their raw form had 
crystalline patterns. The microparticles loaded with TAED had clear peaks corresponding to those 
of TAED, which indicates that the lowering of Tm of TAED loaded particles was indeed caused by 
interaction between PLGA and TAED and not because of crystallisation of TAED as a different 
polymorph. However, the microparticles loaded with SP did not show peaks corresponding with the 
raw SP. DSC reheating of unloaded microparticles just above 50°C showed the transition to be 
reversible, confirming glass transition and that PLGA in the microparticles remained amorphous 
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(Figure 3c). Microparticles containing SP showed recrystallisation peaks after the Tg which was 
not seen in the samples containing only TAED. The DSC thermogram of TIPS particles containing 
both TAED and SP also showed an effect of the presence of PLGA and TAED on the exothermic 
peak of the SP degradation. As explained earlier, the DSC signal was the sum of both exothermic 
and endothermic process and thus the endothermic peak of the TAED melting is not visible.  
3.2 Loading efficiency of TAED and SP in TIPS microparticles  
The theoretical loading of TAED and SP particles was 35.5% (w/w) based on the quantity of 
precursor compound added to the polymer solution during manufacture. These values were based 
on the assumption that all of the compound was loaded into the microparticles during manufacture. 
The experimental loading efficiency measured for TAED was in agreement with the theoretical 
calculation (35.8% ± 1.15 w/w), whereas the value for SP was 3.95% ± 0.05 w/w. The use of water 
as a solvent for SP during microparticle manufacture will have resulted in its decomposition to SC 
and H2O2. Comparison of the absorbance spectra obtained using Attenuated Total Reflection 
Fourier Transform Infrared Spectroscopy (ATR-FTIR) for raw SP and microparticles loaded with 
SP indicate some H2O2 entrapped may have reverted back to SP as the water and solvent was 
removed from polymer matrix during lyophilisation (Figure 4).  
3.3 Validation of neutraliser efficacy and toxicity 
In order to quench the activity of the test antimicrobial agent (i.e. H2O2 and PAA) after a particular 
exposure time, a neutralising agent was introduced to the assay at a pre-determined time-point to 
render the antimicrobial agent inactive. Prior to conducting antimicrobial activity assays, the 
neutralising agent was validated to assure this was effective in inactivating the H2O2 and PAA. 
Furthermore, the neutralising agent may pose toxicity to the target organisms at the concentration 
used. Therefore a toxicity assay was performed against MRSA and CREC. 
Neutraliser efficacy (NE) and neutraliser toxicity (NT) were calculated as: NE = MA/MB, and NT = 
MB/MC, where MA, MB and MC represent the mean number of spores recovered from preparations 
(A), (B), (C) and control populations (D) respectively. Results were based on 10 replicate test 
samples. Using documented criteria[26], the neutraliser efficacy and toxicity ratios were calculated 
as being ≥0.75 for all test-preparations (results not shown) demonstrating that the neutraliser was 
effective against H2O2 and PAA and non-toxic to the test organisms. 
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3.4 Antimicrobial activity of TIPS microparticles  
A series of studies were performed to evaluate the antimicrobial activity of TIPS microparticles 
loaded with SP and TAED. Time kill assays measure the time taken for an antimicrobial compound 
to kill test bacteria. The rate of kill by stabilised PAA was first demonstrated at the minimum 
bactericidal concentration (MBC) values for test microorganisms using an inoculum of 1 × 106 mL–1 
for each test bacteria. The time kill for MRSA and CREC are shown at Figure 5. 
To simulate in vivo application, samples containing an equal quantity of SP and TAED TIPS 
microparticles were initially hydrated by placing in culture medium to expose the loaded pre-cursor 
compounds to an aqueous environment resulting in release of the oxidative species. At pre-
determined time-points, aliquots of the hydrated microparticles were challenged ~106cfu bacteria. 
Loaded microparticles hydrated for 1.5 hours significantly reduced the numbers of CREC and 
MRSA inoculum challenge (~6 log10 cfu bacteria) to undetectable levels within 4 hours of contact 
time (Figure 5a). Antimicrobial activity of the loaded microparticles continued when pre-activated 
for 1, 3 and 7 days, with a statistically significant reduction in the inoculum challenge occuring 
within 18 hours of contact time (Figures 5b-d). At 14 days hydration, the loaded microparticles 
continued to display a similar trend for antimicrobial activity (~2 log10 cfu and ~1 log10 cfu 
reductions for MRSA and CREC bacteria, respectively) after 18 hours contact time (Figure 5e).   
The minimum inhibitory (MIC) and bactericidal concentration (MBC) were measured to determine 
whether microparticles loaded with TAED and SP were bacteriostatic or bactericidal. The 
MIC/MBC ratio was found to be 18.33 ± 1.77 ppm and 21.11 ± 2.20 ppm for CREC and MRSA 
bacteria, respectively. MRSA and CREC titres of ~6.0 log10 cfu were reduced to below the 
detection limit (10cfu) within 6 hours of contact when exposed to microparticles loaded with TAED 
and SP. Further confirmation that the loaded microparticles were bactericidal was provided by 
culturing the washed pellet re-suspended in sterile PBS in agar plates after exposure to the active 
supernatant for 6 hours, which resulted in no detectable bacteria growth (Figure 5f). 
3.5 In vitro and in vivo biocompatibility  
Preliminary toxicological assessment of the oxidative species released from the loaded 
microparticles was performed in vitro using a mouse fibroblast cell line (L929). The purpose of the 
cytotoxicity test was to determine the biological reactivity of mammalian cell lines following contact 
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with the oxidative species released from the loaded microparticles over a range of time points. 
Supernatant collected from the hydrated microparticles at pre-determined intervals was incubated 
with the fibroblasts. For the majority of incubation times, the level of cytotoxicity (based on 
measuring changes in membrane integrity that occur as a result of cell death) was not elevated 
above background levels obtained for cells alone or cells incubated with supernatant samples 
collected from unloaded microparticles. Increased cytotoxicity occurred only with supernatant 
samples collected before 1.5 hours hydration of the loaded microparticles and incubation of the 
supernatant with cells for 1.5 – 5 hours (Figure 6a).  
Based on the promising in vitro cytotoxicity data, The biocompatibility of TIPS microparticles 
loaded with SP and TAED was investigated in vivo using an intracutaneous reactivity test to 
determine the potential for causing localised reaction and irritation. Subcutaneous injection of the 
microparticles into rats was well-tolerated with no clinical or local sign of erythema and edema at 
the implant site at any of the time-points. Histology of the implant site revealed the microparticles to 
be present at all experimental time points, eliciting a minimal or slight granulomatous inflammatory 
reaction (Figure 6b). 
4. DISCUSSION 
The porous structure observed in unloaded TIPS microparticles was created by dimethyl carbonate 
(DMC) solvent crystals formed when the droplet of polymer solution froze as it entered the liquid 
nitrogen quenching bath. The frozen solvent was removed by lyophilisation resulting in the highly 
porous polymer structure. The different surface morphology observed with microparticles loaded 
with TAED was due to the introduction of acetonitrile (ACN) to the polymer solution as a solvent for 
TAED. The melting temperature of ACN (-45°C) and the interaction with the polymer solution is 
likely to have changed the formation of solvent crystal shapes in the frozen droplet structure[28]. 
The increased porosity observed with microparticles loaded with SP is likely to have resulted from 
the inclusion of water introduced to the polymer mix to dissolve the SP. This may have caused 
changes to the thermal energy of the system, altering the shape of the solvent crystals formed in 
the droplet during the freezing process[28]. Mixing aqueous solutions into a hydrocarbon-rich 
polymer is challenging[29]. It is likely only limited quantities of H2O2 produced from SP dissolved in 
water during manufacture would become entrapped in microparticles due to its low molecular 
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weight, the hydrophobicity of the polymer, and the expected high diffusion coefficient from the 
polymers matrices[29]. Further decomposition of H2O2 into water and oxygen whilst in the aqueous 
solvent and polymer solvent (DMC) is likely to have occurred[29,30].  As SP is an adduct with 
hydrogen peroxide it would be expected to reform during the lyophilization process if the hydrogen 
peroxide has not degraded. Some of the H2O2 formed may also have been removed along with 
water from the microparticles during lyophilisation, similar to that observed in previous studies[31]. 
However, the microbiology data indicate the quantity of SP loaded is sufficient to achieve biocidal 
activity. Further studies are necessary to characterize the behaviour of SP during the 
manufacturing process. 
The antimicrobial activity of TAED and SP is attributed to the formation of PAA together with its 
anions via the reaction of the acyl group in TAED with the hydroperoxide anion from SP. PAA has 
a higher oxidation potential and stronger nucleophilic abilities than H2O2 produced by SP alone[20, 
33]. H2O2 is active against a wide range of microorganisms, including bacteria, yeasts, fungi, 
viruses and PAA inactivates Gram-positive and Gram-negative bacteria, bacterial spores, fungi, 
and yeasts at lower concentrations than H2O2 [20, 21, 34]. The current feasibility study used MRSA 
and CREC as representative Gram positive and Gram negative models, respectively, to gauge the 
efficacy of oxidative biocide-precursor compounds released from TIPS microparticles. Further 
studies that reflect polymicrobial environments will be necessary to determine whether the current 
technology is suitable as a broad-spectrum antimicrobial approach. It should be noted that, to date, 
there is no evidence showing bacterial resistance or tolerance to oxidative biocides. This can be 
attributed to the mechanism of action of oxidative biocides that involves degradation of many 
components of the cell, including membrane lipids, proteins and genomic material, thus reducing 
the likelihood of bacterial resistance. 
For clinical acceptance, the oxidative species must be efficacious whilst not eliciting to tissue 
damage. Existing modes for delivering oxidative species in clinic, such as high concentrations of 
H2O2 (3%/~1.2 M) as a topical antiseptic for surgical wounds, notably in endodontics and 
periodontitis[35], risk causing collateral tissue damage and are unsuitable for treating infected 
wounds with a large surface area or where repeated application is necessary[7]. The in vitro 
cytotoxicity observed was lower than expected since PAA and H2O2, formed by the microparticles 
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loaded with TAED and SP, are strong oxidising agents that can cause tissue damage at high 
concentrations. Previous studies investigating the cytotoxicity of different concentrations of H2O2 
have indicated the cytotoxic effects on cells are both dose-dependent and time-dependent[8,36].  
We observed a similar trend, with increased cytotoxicity occurring in samples collected from 
microparticles after shorter periods of hydration combined with longer contact time between the 
supernatant and cells. This time point was primarily included in the current proof of concept study 
to identify the boundary conditions within which effective and safe use of the microparticles is likely 
to be achieved. However, it should be noted that the incubation conditions used for this time point 
are not truly reflective of exposure to the oxidative biocides likely to occur in vivo. Unlike in vitro 
conditions, implantation in vivo will expose the microparticles to a dynamic physiological 
environment where tissue perfusion is likely to prevent a build-up of the biocidal compounds that 
occur in vitro under static conditions over 5 hrs. The process used to fabricate the microparticles is 
amendable to further optimization in terms of polymer degradation and release of the precursor 
compounds, as well as the amount of compounds loaded into microparticles. This provides scope 
for future studies to adjust the release of oxidative biocides to match requirements associated with 
different uses.  
In vivo implantation revealed evidence of the expected tissue-response continuum to microparticle 
degradation at all time-points[22, 23]. No discernible difference in the response was observed 
between groups treated with a combination of the loaded microparticles and those containing the 
individual precursor compounds or unloaded control microparticles. Although the earliest histology 
time point was beyond the time point for peak release of oxidative biocide in vitro, the lack of any 
signs of an adverse tissue reaction, such as necrosis, that would be expected in response to 
toxicity caused by oxidative biocides suggests the precursor-loaded microparticles were well 
tolerated. The data collected to date concur with the low toxicity effects observed in vitro and are 
supported by existing data on the low risk of acute toxicity associated with SP and TAED[37,38].  
Future studies need before clinical translation will investigate whether the quantities of precursor 
compounds loaded into the microparticles are efficacious in tackling bacterial infections using pre-
clinical in vivo models that reflect polymicrobial environments, such as chronic wounds related to 
diabetic foot ulceration or orthopaedic implant surgery. Likewise, further pre-clinical testing will be 
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aimed at verifying non-toxicity of SP and TAED associated with long-term exposure to SP and 
TAED that occurs whilst the microparticles completely degrade, as well as their antimicrobial 
activity beyond 14 days demonstrated in the current study. 
The TIPS microparticle technology provides an effective delivery vehicle for targeted and controlled 
release of the peroxygen donor, SP, combined with an acetyl donor, TAED, resulting in delivery of 
antimicrobial activity via a dynamic equilibrium mixture of H2O2 and PAA. The hydrophobic polymer 
PLGA shelters the precursor compounds from the aqueous tissue environment found in vivo. 
Degradation of the PLGA via hydrolysis in aqueous environments provides sustained delivery of 
non-toxic concentrations, which counters rapid clearance and decomposition of the oxidative 
species, thus avoiding the need for repeated treatment to maintain an effective local concentration.  
5. CONCLUSIONS  
Antibiotic resistance poses a significant risk to human health; therefore, novel approaches to 
combat infection are urgently needed.  Re-evaluation of existing small molecules with well- 
established biocidal properties and a low propensity to give rise to resistance, especially in terms 
of optimising their mode of delivery, could offer an accelerated pathway to clinical application for a 
range of new therapeutic products.  
The current study demonstrates for the first time it is possible to deliver PAA and H2O2 with 
localised potent, non-toxic antimicrobial activity using pre-cursor compounds TAED and SP loaded 
into TIPS microparticles. The TIPS technology can provide an innovative antimicrobial alternative 
to classic antibiotic agents and could serve as adjunctive or replacement therapy. Although our 
study reports the use for topical treatments, it is reasonable to expect that the technology could be 
adapted for oral or systemic delivery. The availability of a wide range of acetyl donors and a 
smaller range of peroxygen donors, combined with significant design variation for the particles 
themselves (including rate of degradation via hydrolysis), offers great potential for the creation of 
bespoke approaches to different clinical conditions. 
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Figure Captions 
Figure 1. Decomposition of TAED and SP compounds into secondary products. SP decomposes 
into H2O2 that reacts with TAED through hydrolysis and perhydrolysis to produce 
triacetylethylenediamine (TriAED) and diacetylethylenediamine (DAED), resulting in the release of 
two moles of peracetic acid (PAA) or acetic acid (AA). 
Figure 2. Scanning electron microscopy (SEM) images showing TIPS microparticles before and 
after in vitro hydration for 28 days. (a) Unloaded, (b) TAED- and (c) SP-loaded microparticles 
formed are highly porous with highly ordered interconnected channels. Higher magnification inset 
images for figures a-c show unique structural features produced with each type of microparticle. 
Figures (d) unloaded, (e) TAED, (f) SP show the changes in the TIPS microparticles morphology 
after they were hydrated for 28 days in minimum essential medium eagle (EMEM media). Higher 
magnification (inset) show a more open pore structure due to the bulk erosion of the polymer 
matrix. 
Figure 3. Thermal characterisation of TIPS particles. (a) Differential scanning calorimetry - DSC, (b) 
Thermogravimetry - TGA and (c) reheating SP and TAED loaded TIPS in DSC, (d) Powder X-ray 
Diffraction - PXRD data for Control, TAED and SP TIPS microparticles and the compounds in their 
raw format. 
Figure 4. Absorbance spectra of raw SP, unloaded microparticles and SP loaded microparticles. 
The loading of SP into the microparticles was confirmed by Attenuated Total Reflection Fourier 
Transform Infrared Spectroscopy (ATR-FTIR) - Perkin Elmer series 2000. The raw SP spectrum 
has distinct peaks at the wavelengths of 1298nm and 2976nm. These peaks were also present at 
the spectrum of SP loaded microparticles but were not present in the unloaded microparticles. 
Figure 5. Antimicrobial activity of the microparticles loaded with TAED + SP against CREC and 
MRSA for 14 days. The antimicrobial activity for the hydration times (a) 1.5 hours (p<0.05), (b) 1 
day (p<0.01), (c) 3 days (p<0.05) (d) 7 days (p,0.05) & (e) 14 days (ns) and different contact times. 
Hydration time is the amount of time the samples are incubated in complete EMEM medium before 
supernatant samples are collected. Contact time is the amount of time the supernatant is incubated 
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with bacteria. The TAED+SP TIPS microparticles have antimicrobial activity that lasts for up to 14 
days. All data points include error bars. (Some error bars are smaller than data point symbols.) 
Statistical evaluation was performed by the Friedman test. (f) The loaded microparticles are 
bactericidal and not bacteriostatic. A bacterial inoculum challenge that had been exposed for 6 
hours to the active supernatant collected from the loaded microparticles and incubated for 48 hours 
did not show any sign of growth. Two-Way ANOVA with Dunnett's test for multiple comparisons 
was used to examine if there was a significant difference between the groups. The p values shown 
refer to test samples compared with untreated inoculum. 
Figure 6. Biocompatibility of TAED and SP when incubated with cells or injected into rats. (a) 
Cytotoxicity of supernatant collected from loaded and unloaded microparticles after different times 
of hydration and contact. No significant increase in cytotoxicity to L929 cells was measured for the 
majority of incubation conditions. An increase occurred at 1.5 hours hydration time and for contact 
times from 0.5-5 hours if compared to EMEM Control (p<0.001). A Two-Way ANOVA with 
Dunnett's test for multiple comparisons was used to examine if there was a significant difference 
between the groups. The p values shown refer to test samples compared with untreated cells 
incubated in medium only.  
(b) Histology of the implant site after 7, 14 and 21 days.  No discernible difference in the tissue 
response was observed between the unloaded microparticles and those loaded with TAED and SP. 
The microparticles lose their structure over time and become infiltrated by inflammatory cells and 
fibrovascular tissue that forms part of the expected tissue response continuum as the 
microparticles degrade. 
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